163 related articles for article (PubMed ID: 35626300)
21. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
[TBL] [Abstract][Full Text] [Related]
22. Macroscopic Portal Vein Thrombosis in HCC Patients.
Akkiz H; Carr BI; Kuran S; Karaoğullarından Ü; Üsküdar O; Tokmak S; Arslan B; Doran F; Balli HT; Ülkü A; Akçam TA; Bahçeci Hİ; Polat KY; Örmeci N; Şimşek H; Sonsuz A; Demir A; Altıntaş E; Demir M; Yalçın K; Ekinci N; Harmancı Özakyol A; Yücesoy M; Uygun A; Guerra V; Delik A; Tokat Y; Yilmaz S; Bektaş A; Kılıç M
Can J Gastroenterol Hepatol; 2018; 2018():3120185. PubMed ID: 30009156
[TBL] [Abstract][Full Text] [Related]
23. Tumor multifocality and serum albumin levels can identify groups of patients with hepatocellular carcinoma and portal vein thrombosis having distinct survival outcomes.
Carr BI; Guerra V; Donghia R; Yilmaz S
Ann Med Surg (Lond); 2021 Jun; 66():102458. PubMed ID: 34141428
[TBL] [Abstract][Full Text] [Related]
24. Benign and malignant portal vein thrombosis: differentiation by CT characteristics.
Tublin ME; Dodd GD; Baron RL
AJR Am J Roentgenol; 1997 Mar; 168(3):719-23. PubMed ID: 9057522
[TBL] [Abstract][Full Text] [Related]
25. Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients.
Benevento F; Pecorelli A; Stefanescu H; Sparchez Z; Vukotic R; Pettinari I; Grigoras CA; Tovoli F; Ravaioli F; Stefanini B; Andreone P; Piscaglia F
J Hepatocell Carcinoma; 2023; 10():473-482. PubMed ID: 37007210
[TBL] [Abstract][Full Text] [Related]
26. Trends in Tumor Indices in Relation to Increased Hepatocellular Carcinoma Size: Evidence for Tumor Evolution as a Function of Growth.
Carr BI; Guerra V; Donghia R; Yilmaz S
J Gastrointest Cancer; 2020 Dec; 51(4):1215-1219. PubMed ID: 33006073
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic role of contrast-enhanced ultrasonography versus conventional B-mode ultrasonography in cirrhotic patients with early hepatocellular carcinoma: a retrospective study.
Jiang Y; Zhang M; Zhu Y; Zhu D
J Gastrointest Oncol; 2021 Oct; 12(5):2403-2411. PubMed ID: 34790401
[TBL] [Abstract][Full Text] [Related]
28. Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment.
Zhang XY; Luo Y; Wen TF; Jiang L; Li C; Zhong XF; Zhang JY; Ling WW; Yan LN; Zeng Y; Wu H
World J Gastroenterol; 2014 Sep; 20(35):12628-36. PubMed ID: 25253968
[TBL] [Abstract][Full Text] [Related]
29. Janus Kinase-2 Mutation Associated Portal Vein Thrombosis Complicating Liver Cirrhosis and Hepatocellular Carcinoma.
Rabie H; Othman W; Elsabaawy DM; Elshemy EE; Abdelmageed N; Khalaf FA; Bedair HM
Asian Pac J Cancer Prev; 2021 Jan; 22(1):267-275. PubMed ID: 33507708
[TBL] [Abstract][Full Text] [Related]
30. Relationships Between Indices of Tumor Aggressiveness in Hepatocellular Carcinoma.
Carr BI; Guerra V; Donghia R; Yilmaz S
J Gastrointest Cancer; 2021 Dec; 52(4):1340-1349. PubMed ID: 34611834
[TBL] [Abstract][Full Text] [Related]
31. Portal Vein Thrombosis and Markers of Inflammation in Hepatocellular Carcinoma.
Carr BI; Guerra V; Donghia R
J Gastrointest Cancer; 2020 Dec; 51(4):1141-1147. PubMed ID: 32851544
[TBL] [Abstract][Full Text] [Related]
32. Portal vein thrombosis with contrast-enhanced ultrasound in a patient with hepatocellular carcinoma: a case study.
Salman S
Australas J Ultrasound Med; 2012 May; 15(2):67-70. PubMed ID: 28191145
[TBL] [Abstract][Full Text] [Related]
33. Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study.
Nadinskaia MY; Kodzoeva KB; Ulyanova KA; Volkova AS; Rogacheva SI; Dekhanov AS; Strelkova DA; Ivashkin VT
Ter Arkh; 2019 Mar; 91(2):73-81. PubMed ID: 31094175
[TBL] [Abstract][Full Text] [Related]
34. Folate levels in hepatocellular carcinoma patients with portal vein thrombosis.
Malaguarnera G; Catania VE; Latteri S; Borzì AM; Bertino G; Madeddu R; Drago F; Malaguarnera M
BMC Gastroenterol; 2020 Nov; 20(1):375. PubMed ID: 33172390
[TBL] [Abstract][Full Text] [Related]
35. Differentiating malignant and benign focal liver lesions in children using CEUS LI-RADS combined with serum alpha-fetoprotein.
Jiang ZP; Zeng KY; Huang JY; Yang J; Yang R; Li JW; Qiu TT; Luo Y; Lu Q
World J Gastroenterol; 2022 Jun; 28(21):2350-2360. PubMed ID: 35800178
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic Value of CEUS LI-RADS Version 2017 in Differentiating AFP-Negative Hepatocellular Carcinoma from Other Primary Malignancies of the Liver.
Wang P; Nie F; Dong T; Yang D; Liu T; Wang G
Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943487
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Contrast Enhanced Ultrasound With Contrast Enhanced Computed Tomography for the Diagnosis of Hepatocellular Carcinoma.
Moudgil S; Kalra N; Prabhakar N; Dhiman RK; Behera A; Chawla YK; Khandelwal N
J Clin Exp Hepatol; 2017 Sep; 7(3):222-229. PubMed ID: 28970709
[TBL] [Abstract][Full Text] [Related]
38. Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography.
Li R; Yang D; Tang CL; Cai P; Ma KS; Ding SY; Zhang XH; Guo DY; Yan XC
BMC Cancer; 2016 Feb; 16():158. PubMed ID: 26917546
[TBL] [Abstract][Full Text] [Related]
39. Incidence and clinical presentation of portal vein thrombosis in cirrhotic patients.
Cagin YF; Atayan Y; Erdogan MA; Dagtekin F; Colak C
Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):499-503. PubMed ID: 27733319
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of bland from neoplastic thrombus of the portal vein in patients with hepatocellular carcinoma: application of susceptibility-weighted MR imaging.
Li C; Hu J; Zhou D; Zhao J; Ma K; Yin X; Wang J
BMC Cancer; 2014 Aug; 14():590. PubMed ID: 25123782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
